These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 761439)

  • 1. Effect of alpha-methyldopa on cardiac output in hypertension.
    Safar ME; London GM; Levenson JA; Kheder MA; Aboras NE; Simon AC
    Clin Pharmacol Ther; 1979 Mar; 25(3):266-72. PubMed ID: 761439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methyldopa and neural control of circulation in essential hypertension.
    Mancia G; Ferrari A; Gregorini L; Bianchini C; Terzoli L; Leonetti G; Zanchetti A
    Am J Cardiol; 1980 Jun; 45(6):1237-43. PubMed ID: 6990740
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of hypotensive substances (hypothiazide, guanetidine, alpha-methyldopa) on basic hemodynamic indices].
    Glezer GA
    Kardiologiia; 1968 Aug; 8(8):113-8. PubMed ID: 5727457
    [No Abstract]   [Full Text] [Related]  

  • 4. Antiadrenergic therapy: special aspects in hypertension in the elderly.
    Messerli FH; Dreslinski GR; Husserl FE; Suarez DH; MacPhee AA; Frohlich ED
    Hypertension; 1981; 3(6 Pt 2):II-226-9. PubMed ID: 7298137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-hypertensive adrenergic-blocking agents: effects on sodium balance, the renin-angiotensin system and haemodynamics.
    Safar ME; Weiss YA; Corvol PL; Menard JE; London GM; Milliez PL
    Clin Sci Mol Med Suppl; 1975 Jun; 2():93s-95s. PubMed ID: 802649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic changes in long-term -methyldopa therapy of essential hypertension.
    Lund-Johansen P
    Acta Med Scand; 1972 Sep; 192(3):221-6. PubMed ID: 5055268
    [No Abstract]   [Full Text] [Related]  

  • 7. [The effect of alpha-methyldopa and guanethidine on hemodynamic shifts in the orthostatic position in patients with arterial hypertension].
    Glezer GA; Moskalenko NP
    Kardiologiia; 1972 Dec; 12(12):55-60. PubMed ID: 4661921
    [No Abstract]   [Full Text] [Related]  

  • 8. Hemodynamic and cardiac effects of centrally acting antihypertensive drugs.
    Frohlich ED; Messerli FH; Pegram BL; Kardon MB
    Hypertension; 1984; 6(5 Pt 2):II76-81. PubMed ID: 6150003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative evaluation of the therapeutic effect and mechanism of action of isobarin and aldomet in hypertension].
    Erina EV; Zamyslova KN; Il'ina LI; Glezer GA; Pershakova LP; Vyshnepol'skiĭ IuIa; Labeeva TN
    Kardiologiia; 1967 Mar; 7(3):35-41. PubMed ID: 4883577
    [No Abstract]   [Full Text] [Related]  

  • 10. Haemodynamic changes in long-term therapy of essential hypertension: a comparative study of diuretics, alpha-methyldopa and clonidine.
    Lung-Johansen P
    Clin Sci Mol Med Suppl; 1973 Aug; 45 Suppl 1():199s-203. PubMed ID: 4593565
    [No Abstract]   [Full Text] [Related]  

  • 11. Changes in plasma and extracellular fluid volume during long-term treatment with alpha-methyldopa in 11 thiazide-treated patients with essential hypertension.
    Leth A; Ibsen H
    Acta Med Scand; 1975; 198(1-2):45-8. PubMed ID: 1166823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of reserpine, guanethidine and methyldopa on cardiac output and its distribution.
    Kisin I; Yuzhakov S
    Eur J Pharmacol; 1976 Feb; 35(2):253-60. PubMed ID: 1248504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical management of primary hypertension. 2.
    Page LB; Sidd JJ
    N Engl J Med; 1972 Nov; 287(20):1018-23. PubMed ID: 4568395
    [No Abstract]   [Full Text] [Related]  

  • 14. The cardiovascular pharmacology of methyldopa using graphic segmental circulatory analysis.
    Osborne MW; Wenger JJ; Barrett RJ; Zanko MT
    J Pharmacol Exp Ther; 1974 May; 189(2):405-13. PubMed ID: 4829222
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of methyldopa treatment on cardiac function and myocardial blood flow in mongrel dogs.
    Lokhandwala MF; Buckley JP; Jandhyala BS
    Proc Soc Exp Biol Med; 1976 Mar; 151(3):466-70. PubMed ID: 1257244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of alpha-methyldopa (dopegit) on some blood circulation indices].
    Glezer GA; Pushkar' IuT; Spibak GL; Moskalenko NP; Aranas'eva LS; Soboleva VA
    Sov Med; 1969 Feb; 32(2):21-6. PubMed ID: 5380419
    [No Abstract]   [Full Text] [Related]  

  • 17. Abnormal baroreflex control of heart rate in normotensive young subjects with a family history of essential hypertension.
    Iwase N; Takata S; Okuwa H; Ogawa J; Ikeda T; Hattori N
    J Hypertens Suppl; 1984 Dec; 2(3):S409-11. PubMed ID: 6599692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orally administered methyldopa. Hemodynamic effects in the presence and absence of congestive heart failure.
    Kranz PD; Haft JI; Venkatachalapathy D; Shahabadi AE
    Arch Intern Med; 1974 Sep; 134(3):478-83. PubMed ID: 4853485
    [No Abstract]   [Full Text] [Related]  

  • 19. Vasopressin reduces cardiac function and augments cardiopulmonary baroreflex resistance increases in man.
    Ebert TJ; Cowley AW; Skelton M
    J Clin Invest; 1986 Apr; 77(4):1136-42. PubMed ID: 3514673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Change in the hemodynamic indices under the influence of measured physical load in hypertensive patients treated with alpha-methyldopa].
    Khalfen ESh; Mareeva TN
    Kardiologiia; 1974 Apr; 14(4):86-92. PubMed ID: 4836800
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.